Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Cbl-b inhibitors(E3 ubiquitin-protein ligase CBL-B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic breast cancer | Preclinical | United States | 29 Apr 2025 | |
Metastatic breast cancer | Preclinical | United States | 29 Apr 2025 |